Roundview Capital LLC Novo Nordisk A S Transaction History
Roundview Capital LLC
- $1.4 Billion
- Q4 2024
A detailed history of Roundview Capital LLC transactions in Novo Nordisk A S stock. As of the latest transaction made, Roundview Capital LLC holds 54,738 shares of NVO stock, worth $4.57 Million. This represents 0.34% of its overall portfolio holdings.
Number of Shares
54,738
Previous 49,342
10.94%
Holding current value
$4.57 Million
Previous $5.88 Million
19.86%
% of portfolio
0.34%
Previous 0.44%
Shares
30 transactions
Others Institutions Holding NVO
# of Institutions
1,878Shares Held
336MCall Options Held
11.9MPut Options Held
10.6M-
Jennison Associates LLC19.9MShares$1.66 Billion1.06% of portfolio
-
Bank Of America Corp Charlotte, NC15.5MShares$1.29 Billion0.11% of portfolio
-
Gqg Partners LLC Ft. Lauderdale, FL13MShares$1.08 Billion1.67% of portfolio
-
Ken Fisher Fisher Asset Management, LLC | Camas, Wa12.6MShares$1.05 Billion0.44% of portfolio
-
Morgan Stanley New York, NY12.2MShares$1.02 Billion0.08% of portfolio
About NOVO NORDISK A S
- Ticker NVO
- Exchange OTC
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 2,257,289,984
- Market Cap $188B
- Description
- Novo Nordisk A/S, a healthcare company, engages in the research, development, manufacture, and marketing of pharmaceutical products worldwide. It operates in two segments, Diabetes and Obesity care, and Biopharm. The Diabetes and Obesity care segment provides products in the areas of insulins, GLP-1 and related delivery systems, oral antidiabeti...